Marian Gorecki
Fondateur chez Valin Technologies Ltd.
Profil
Marian Gorecki was the founder of MediWound Ltd.
(founded in 2000) and held the title of Independent Director from 2001 to 2017.
Dr. Gorecki is also the founder of Valin Technologies Ltd.
Dr. Gorecki's current job is as a Director at Pam-Bio Ltd.
since 2019.
Dr. Gorecki's former jobs include being Chairman at Thrombotech Ltd., Independent Director at OPKO Biologics Ltd.
from 2012 to 2014, Non-Executive Director at SciGen Pte Ltd.
from 2005 to 2011, Director at Vaxil Bio Ltd., Chief Scientist & General Manager at Savient Pharmaceuticals, Inc., and Associate Professor at Weizmann Institute of Science from 1982 to 1986.
Dr. Gorecki's education includes a graduate degree from Massachusetts Institute of Technology and a doctorate degree from Weizmann Institute of Science.
Postes actifs de Marian Gorecki
| Sociétés | Poste | Début |
|---|---|---|
Pam-Bio Ltd.
 Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Pam-Bio Ltd. develops drug therapy for acute bleeding conditions. The company was founded by Abd Al-Roof Higazi and Nuha Higazi on April 27, 2014 and is headquartered in Nazareth, Israel. | Directeur/Membre du Conseil | 30/04/2019 |
| Valin Technologies Ltd. | Fondateur | - |
Anciens postes connus de Marian Gorecki
| Sociétés | Poste | Fin |
|---|---|---|
| MEDIWOUND LTD. | Fondateur | 22/06/2017 |
| VAXIL BIO LTD. | Directeur/Membre du Conseil | 04/01/2017 |
OPKO Biologics Ltd.
 OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Directeur/Membre du Conseil | 01/03/2014 |
| SCIGEN LIMITED | Directeur/Membre du Conseil | 03/03/2011 |
| Weizmann Institute of Science | Corporate Officer/Principal | 01/01/1986 |
Formation de Marian Gorecki
| Massachusetts Institute of Technology | Graduate Degree |
| Weizmann Institute of Science | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MEDIWOUND LTD. | Health Technology |
| VAXIL BIO LTD. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Health Technology |
SciGen Pte Ltd.
 SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
Thrombotech Ltd.
 Thrombotech Ltd. Medical SpecialtiesHealth Technology Thrombotech Ltd. is an Israel-based biotechnological company that is based on years of cutting-edge thrombotic research at the Hadassah Medical Center in Jerusalem. Thrombotech developed a peptide called THR-18, which allows the existing thrombolytic stroke medication to easily dissolve blood clots, extending its short therapeutic time window and diminishing life-threatening side effects. The company was founded in 2000 and is headquartered in Rehovot, Israel. | Health Technology |
Pam-Bio Ltd.
Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Pam-Bio Ltd. develops drug therapy for acute bleeding conditions. The company was founded by Abd Al-Roof Higazi and Nuha Higazi on April 27, 2014 and is headquartered in Nazareth, Israel. | Health Technology |
| Valin Technologies Ltd. |
